Axcelis Technologies Inc (ACLS)

NASD · Technology · Semiconductor Equipment & Materials · USA

Axcelis Technologies Inc is a mid cap company (market value between $2 billion and $10 billion) in the Semiconductor Equipment & Materials industry.

Axcelis Technologies produces ion implantation systems used in semiconductor manufacturing, supplying major chip makers globally. The company provides its Purion family of implanters in high current, high energy and medium current configurations, supplemented by aftermarket offerings such as replacement components, maintenance support and system enhancements.

From its FY2025 annual report (Form 10-K)

Intrinsic value, DCF valuation, financial health and value investing analysis for the Axcelis Technologies Inc stock.

Our verdict on ACLS

Undervalued: intrinsic value $302.45 per share, market price $111.21, margin of safety 63.2% (as of 2026-10-19).

A 10.4x revenue multiple, adjusted for growth and margin, values the shares at $302.45; the price of $111.21 is 63% below that value.

Leak Score: 59/100 on 11 of 12 signals (Weak Signal).

ETFs with the most weight in ACLS

17 more funds hold it; the full list is part of the paid plan.

More on ACLS

Browse

Peers in Semiconductor Equipment & Materials

All 29 Semiconductor Equipment & Materials stocks

Cheaper than ACLS in Semiconductor Equipment & Materials

Is ACLS undervalued or overvalued?

ACLS is undervalued (as of the 2026-10-19 close). A 10.4x revenue multiple, adjusted for growth and margin, values the shares at $302.45; the price of $111.21 is 63% below that value.

What is the intrinsic value of ACLS?

$302.45 per share (as of the 2026-10-19 close), against a market price of $111.21. That is a margin of safety of 63.2%. The value is the average of the valuation methods that apply to this company, recomputed every night after the US close.

What is Axcelis Technologies Inc's Leak Score?

59 out of 100, which we rate "Weak Signal", on 11 of 12 value investing signals.